Abstract
Ocular cicatricial pemphigoid is an uncommon but severe and potentially blinding systemic disease. It shares many pathophysiological features with the other bullous skin diseases such as dermatitis herpetiformis, bullous pemphigoid and pemphigus vulgaris. All of these diseases have circulating antibodies that bind to the basement membrane of mucous membranes. The individual diseases differ by each having a specific component of the basement membrane complex as its antigen. In acute ocular cicatricial pemphigoid, the conjunctiva is infiltrated with neutrophils, macrophages, Langerhans cells and CD8+ and CD4+ T-cells while in the chronic disease the conjunctiva is infiltrated mainly by CD8+ T-cells. There is evidence of activation of these T-cells as CD4+ cells as shown by expression of the interleukin-2 receptor and increased expression of major histocompatibility class II antigens within the tissue. The aetiology of the fibrosis is unknown but increased amounts of several fibrogenic growth factors are demonstrable by immunohistochemistry.
References
Wright P . Cicatrizing conjunctivitis. Trans Ophthalmol Soc UK 1986; 105: 1–17.
Hall RP . The pathogenesis of dermatitis herpetiformis: recent advances. J Am Acad Dermatol 1987; 16: 1129–44.
Moschella SL, Pillsbury DM, Hurley HJ . Dermatology. Vol. 1. Philadelphia: WB Saunders, 1975: 460–76.
Gruis NA, Bavinck JN, Steijlen PM, Schroeff JG van der, Haeringen A van, Happle R, et al. Genetic linkage between the collagen VII (COL7A1) gene and the autosomal dominant form of dystrophic epidermolysis bullosa in two Dutch kindreds. J Invest Dermatol 1992; 99: 528–30.
Mooney E, Falk RJ, Gammon WR . Studies on complement deposits in epidermolysis bullosa acquisita and bullous pemphigoid. Arch Dermatol 1992; 128: 58–60.
McDonnell PJ, Schofield OM, Spalton DJ, Eady RA . Eye involvement in junctional epidermolysis bullosa. Arch Ophthalmol 1989; 107: 1635–7.
Richter HH, McNutt S . The spectrum of epidermolysis bullosa acquisita. Arch Dermatol 1979; 115: 1325–8.
Woodley DT, Briggaman RA, O'Keefe EJ, Inman AO, Queen LL, Gammon WR . Identification of the skin basement-membrane autoantigen in epidermolysis acquisita. N Engl J Med 1984; 310: 1007–13.
Yancey KB, Lawley TJ . The immunology of the skin. In: Middleton E, Reed CE, Ellis EF, editors. Allergy: principles and practice. St Louis: Mosby, 1988: 206–23.
Zierhut M, Theil HJ, Weidle EG, Steudhl KP, Sonnichsen K, Schaumburg-Lever G . Ocular involvement in epidermolysis bullosa acquisita. Arch Ophthalmol 1989; 107: 398–401.
Bean SF, Halubar K, Gillett RB . Pemphigus involving the eyes. Arch Dermatol 1975; 111: 1484–6.
Grando SA, Terman AK, Stupina AS, Glukhenky BT, Romanenko AB . Ultrastructural study of clinically unin-volved skin of patients with pemphigus vulgaris. Clin Exp Dermatol 1991; 16: 359–63.
Judd K, Lever W . Correlation of antibodies in skin and serum with disease severity in pemphigus. Arch Dermatol 1979; 115: 428–32.
Kaplan R, Callen J . Pemphigus associated diseases and induced pemphigus. Clin Dermatol 1983; 1: 42–71.
Korman N . Pemphigus. J Am Acad Dermatol 1988; 18: 1219–38.
Moy R, Jordan R . Immunopathology in pemphigus. Clin Dermatol 1983; 1: 72–83.
Venning V, Frith P, Bron A, Millard P, Wojnarowska F . Mucosal involvement in bullous and cicatricial pemphigoid: a clinical and immunopathological study. Br J Dermatol 1988; 118: 7–15.
Fine JD, Neises GR, Katz SI . Immunofluorescence and immunoelectron microscope studies in cicatricial pemphigoid. J Invest Dermatol 1984; 82: 39–43.
Zillikens D, Arnbach A, Schuessler M, Dummer R, Hartmann AA, Burg G . The interleukin-2 receptor in lesions and serum of bullous pemphigoid. Arch Dermatol Res 1992; 284: 141–5.
Stanley JR . Bullous pemphigoid. In: Jegasothy BV, Lazarus GS, editors. Symposium on blistering disease. Dermatologic clinics. Philadelphia: WB Saunders, 1983: 205–16.
Stanley JR, Woodley D, Katz S . Identification and partial characterisation of pemphigoid antigen extracted from normal human skin. J Invest Dermatol 1984; 82: 108–11.
Regnier M, Vaigot P, Michel S, Prunieras M . Location of bullous pemphigoid antigen in isolated human keratinocytes. J Invest Dermatol 1985; 85: 187–90.
Hardy KM, Perry HO, Pingree GC . Benign mucous membrane pemphigoid. Arch Dermatol 1971; 104: 467–75.
Foster CS, Wilson LA, Ekins MB . Immunosuppressive therapy for progressive ocular cicatricial pemphigoid. Ophthalmology 1982; 89: 340–53.
Foster CS . Cicatricial pemphigoid. Trans Am Ophthalmol soc 1986; 84: 527–663.
Mondino BJ, Brown SI . Ocular cicatricial pemphigoid. Ophthalmology 1981; 88: 95–100.
Lever WF . Pemphigus and pemphigoid: a review of the-advances made since 1964. J Am Acad Dermatol 1979; 1: 2–31.
Ahmed AR, Foster S, Zaltas M, Notani G, Awdeh Z, Alper CA, Yunis EJ . Association of DQw7 (DQB1*0301) with-ocular cicatricial pemphigoid. Proc Natl Acad Sci USA 1991; 88: 11579–82.
Mondino BJ . Cicatricial pemphigoid and erythema multiforme. Ophthalmology 1990; 97: 939–52.
Mondino BJ, Brown SI, Rabin BS . Autoimmune phenomenon of the external eye. Trans Am Acad Ophthalmol 1978; 85: 801.
Mondino BJ, Brown SI, Lempert S, Jenkins MS . The acute manifestations of ocular cicatricial pemphigoid: diagnosis and treatment. Ophthalmology 1979; 86: 543–52.
Mondino BJ, Ross AN, Rabin BS, Brown SI . Autoimmune phenomena inocular cicatricial pemphigoid. Am J Ophthalmol 1977; 83: 443–50.
Bernauer W, Wright P, Dart JKG, Leonard JN, Lightman S . The conjunctiva in acute and chronic mucous membrane pemphigoid: an immunohistochemical analysis. Ophthalmology 1993; 100: 339–46.
Dabelsteen E, Ullman S, Thomsen K . Demonstration of basement membrane autoantibodies in patients with benign mucous membrane pemphigoid. Acta Derm Venereol 1974; 54: 189–92.
Franklin RM, Fitzmorris CT . Antibodies against conjunctival basement membrane zone. Arch Ophthalmol 1983; 101: 1611–13.
Leonard JN, Hobday CM, Haffenden GP . Immunofluores-cent studies in ocular cicatricial pemphigoid. Br J Dermatol 1988; 118: 209–17.
Person JR, Rogers RS III. Bullous and cicatricial pemphigoid: clinical, histopathologic, and immunopathologic correlations. Mayo Clin Proc 1977; 52: 54–66.
Waltman SR, Yarian D . Circulating autoantibodies in ocular pemphigoid. Am J Ophthalmol 1974; 77: 891–94.
Niimi Y, Zhu XJ, Bystryn JC . Identification of cicatricial pemphigoid antigens. Arch Dermatol 1992; 128: 54–7.
Rice BA, Foster CS . Immunopathology of cicatricial pemphigoid affecting the conjunctiva. Ophthalmology 1990; 97: 1476–83.
Jordan RE, Schroeter AL, Good RA . The complement system in bullous pemphigoid. II. Immunofluorescent evidence for both classical and alternate-pathway activation. Clin Immunol Immunopathol 1975; 3: 307–14.
Holubar K, Wolff K, Konrad K . Ultrastructural localization of immunoglobulins in bullous pemphigoid skin. J Invest Dermatol 1975; 64: 220–27.
Diaz LA, Calvanico NJ, Tomasi TB . Bullous pemphigoid antigen: isolation from normal human skin. J Immunol 1977; 118: 605–8.
Sacks EH, Wieczorek R, Jakobiec FA, Knowles DM . Lymphocytic subpopulations in the normal human conjunctiva: a monoclonal antibody study. Ophthalmology 1986; 93: 1276–83.
Roat MI, Sossi G, Thoft RA . Hyperproliferation of conjunctival fibroblasts from patients with cicatricial pemphigoid. Arch Ophthalmol 1989; 107: 1064–7.
Liboiroat E, Pelosi E, Di Francesco P, Gallanari P, Petrini M, Sposi NM . The EL2 rat fibroblast line: differential effects of growth factors (EGF, PDGF, FGF, TPA and TGF-β) on cell proliferation and c-fos expression. Ann NY Acad Sci 1987; 511: 318–28.
Muller R, Bravo R, Burckhardt J, Curran T . Induction of c-fos gene and protein by growth factors precedes activation of c-myc. Nature 1984; 312: 716–20.
Hunt LE, Vergnes JP, Roat MI . Altered proto-oncogene expression by conjunctival fibroblasts in cicatricial pemphigoid. Invest Ophthalmol Vis Sci 1991; 32(Suppl): 938.
Rogers RS III, Seehafer JR, Perry HO . Treatment of cicatricial (benign mucous membrane) pemphigoid with dapsone. J Am Acad Dermatol 1982; 6: 215–23.
Tauber J, Jabbur N, Foster CS . Improved detection of disease progression in ocular cicatricial pemphigoid. Cornea 1992; 11: 446–51.
Lang PG . Sulfones and sulfonamides in dermatology today. J Am Acad Dermatol 1979; 1: 479–92.
Booth SA, Moody CE, Dahl MV, Herron MJ, Nelson RD . Dapsone suppresses integrin-mediated neutrophil adherence function. J Invest Dermatol 1992; 98: 135–40.
Gilman AG, Goodman LS, Rall TW, Murad F . The pharmacological basis of therapeutics. New York: Macmillan, 1985.
Lin JX, Vilcek J . Tumour necrosis factor and interleukin-1 cause a rapid and transient stimulation of c-fos and c-myc mRNA levels in human fibroblasts. J Biol Chem 1987; 262: 11908–11.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Elder, M., Lightman, S. The immunological features and pathophysiology of ocular cicatricial pemphigoid. Eye 8, 196–199 (1994). https://doi.org/10.1038/eye.1994.45
Issue Date:
DOI: https://doi.org/10.1038/eye.1994.45
Keywords
- T-cells
- Cicatricial pemphigoid
- Conjunctiva
- Fibrogenic cytokines
- HLA-DR
This article is cited by
-
Ocular Cicatricial Pemphigoid
Current Ophthalmology Reports (2020)
-
Ocular cicatricial pemphigoid: Manifestations and management
Current Allergy and Asthma Reports (2005)
